Terra Innovatum Global to Participate at Upcoming Investor & Industry Conferences

Core Viewpoint - Terra Innovatum Global N.V. is progressing towards regulatory approval and commercialization of its SOLO micro-modular nuclear reactor, with expectations for deployment in 2027 and customer deliveries in 2028 [1][6]. Company Overview - Terra Innovatum aims to make nuclear power accessible through scalable and safe micro-reactor solutions, delivering energy one megawatt electric (MWe) at a time [3][5]. - The SOLO™ Micro-Modular Reactor (SMR™) is designed to provide efficient, safe, and environmentally friendly energy, addressing global energy shortages [5][6]. Technological Advancements - SOLO™ is engineered to meet global energy demands with a market-ready solution, utilizing readily available commercial components to ensure rapid deployment and cost predictability [6]. - The reactor supports both Low Enriched Uranium (LEU+) and High-Assay Low-Enriched Uranium (HALEU), allowing for adaptability to future fuel supplies [6]. Applications and Benefits - SOLO™ offers versatile applications, including CO2-free power solutions for data centers, remote towns, and large-scale industrial operations in sectors like cement, oil and gas, and mining [7]. - The reactor can also provide heat for industrial processes and produce radioisotopes for medical applications, contributing to oncology research and cancer treatment [7]. Upcoming Events - Terra Innovatum will participate in several industry conferences to showcase SOLO's technological advancements and regulatory roadmap, including events in New York, London, and Paris from February to March 2026 [2][4].